Commonwealth Equity Services’s Standard BioTools LAB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-113,000
| Closed | -$198K | – | 4230 |
|
2024
Q4 | $198K | Sell |
113,000
-51,993
| -32% | -$91.1K | ﹤0.01% | 3763 |
|
2024
Q3 | $318K | Buy |
164,993
+8,802
| +6% | +$17K | ﹤0.01% | 3300 |
|
2024
Q2 | $276K | Hold |
156,191
| – | – | ﹤0.01% | 3361 |
|
2024
Q1 | $423K | Buy |
156,191
+113,277
| +264% | +$307K | ﹤0.01% | 2963 |
|
2023
Q4 | $95K | Buy |
42,914
+12,832
| +43% | +$28.4K | ﹤0.01% | 3678 |
|
2023
Q3 | $87K | Hold |
30,082
| – | – | ﹤0.01% | 3586 |
|
2023
Q2 | $58K | Hold |
30,082
| – | – | ﹤0.01% | 3647 |
|
2023
Q1 | $58 | Hold |
30,082
| – | – | ﹤0.01% | 3566 |
|
2022
Q4 | $35K | Buy |
30,082
+14,630
| +95% | +$17K | ﹤0.01% | 3547 |
|
2022
Q3 | $17K | Hold |
15,452
| – | – | ﹤0.01% | 3591 |
|
2022
Q2 | $24K | Hold |
15,452
| – | – | ﹤0.01% | 3556 |
|
2022
Q1 | $55K | Hold |
15,452
| – | – | ﹤0.01% | 3574 |
|
2021
Q4 | $60K | Buy |
+15,452
| New | +$60K | ﹤0.01% | 3514 |
|
2020
Q4 | – | Sell |
-10,571
| Closed | -$78K | – | 3236 |
|
2020
Q3 | $78K | Buy |
+10,571
| New | +$78K | ﹤0.01% | 2909 |
|